Form 4: Owens & Minor EVP, CEO, Patient Direct, Perry A. Bernocchi, Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


Perry A. Bernocchi, EVP, CEO, Patient Direct at Owens & Minor, reports acquiring 44,643 shares of common stock on March 1, 2024, as part of a restricted stock grant.

Summary

  • On March 1, 2024, Perry A. Bernocchi, EVP, CEO, Patient Direct at Owens & Minor, acquired 44,643 shares of common stock.
  • The acquisition was part of a restricted stock grant.
  • The restricted stock vests one-third per year over three years.
  • Following the transaction, Bernocchi beneficially owns 209,537 shares of Owens & Minor common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document simply reports a stock transaction related to executive compensation. It doesn't inherently indicate positive or negative performance.

Positives

  • The acquisition of shares by an executive may signal confidence in the company's future performance.

Future Outlook

The restricted stock grant vests one-third per year over three years, indicating a multi-year incentive structure.

Industry Context

Executive stock ownership is a common practice in publicly traded companies to align management's interests with those of shareholders.

Stakeholder Impact

  • The transaction may have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.

Key Dates

DateDescription
03/01/2024Date of transaction: acquisition of common stock.
03/05/2024Date of signature on the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.